Immunology and Microbiology
Immunity
93%
Immune Response
81%
COVID-19
67%
Immunotherapy
60%
T Cell
58%
Regulatory T Cell
43%
Tumor Necrosis Factor
42%
Intestine Flora
37%
Tumor Immunity
36%
Natural Killer Cell
33%
Severe Acute Respiratory Syndrome Coronavirus 2
33%
Adenoviridae
33%
Cytotoxic T-Cell
32%
Mouse Model
28%
Cytokine Response
28%
Innate Immune System
26%
Microflora
26%
Cytokine
24%
RNAI
23%
Adaptive Immune System
20%
T Cell Proliferation
20%
Wart Virus
20%
Viral Disease
19%
Cancer Immunotherapy
19%
Autoimmunity
18%
Homeostasis
18%
Programmed Death-Ligand 1
16%
Dendritic Cell
16%
Graft-Versus-Host Disease
16%
Immunostimulation
16%
Innate Lymphoid Cell
16%
TLR7
16%
Interleukin 17
16%
Antibody Response
16%
Immunology
16%
Cell Division
16%
Antigen Specificity
16%
CD4
16%
Ciclosporin
16%
Dilution
16%
Virus Antigen
16%
Fc Receptor
16%
Drug Interaction
16%
Autophagy
16%
Monoclonal Antibody
15%
Agonist
15%
Oncogene
13%
Lifespan
12%
Immunosuppression
11%
Tyrosine
11%
Pharmacology, Toxicology and Pharmaceutical Science
Neoplasm
100%
Immunotherapy
93%
Malignant Neoplasm
70%
Cytokine
46%
Diseases
43%
SARS Coronavirus
42%
Receptor
39%
Adverse Event
39%
Liver Injury
31%
Tumor Model
30%
Immunotoxicity
25%
Mouse Model
24%
Tumor Necrosis Factor
22%
Intestine Flora
22%
Virus Infection
22%
Immunoglobulin
22%
Microflora
21%
Monoclonal Antibody
21%
COVID-19 Vaccine
20%
Melanoma
19%
Messenger RNA
19%
Cytokine Release Syndrome
18%
Dasatinib
16%
Colorectal Carcinoma
16%
Respiratory Tract Disease
16%
Coronavirinae
16%
Ciclosporin
16%
Adenoviridae
16%
Imatinib
16%
Drug Interaction
16%
Tumor Microenvironment
14%
Cytotoxic T Lymphocyte Antigen 4
14%
Tumor Growth
13%
Infection
11%
Immune Checkpoint Inhibitor
11%
Pyroptosis
11%
Clinical Trial
11%
Lung Metastasis
10%
Protein Tyrosine Kinase Inhibitor
10%
Colitis
9%
Wild Type Mouse
9%
Experimental Metastasis
9%
Placebo
9%
Immunosuppressive Agent
9%
Infectious Agent
8%
Chemotherapy
8%
Doxorubicin
8%
B Cell Activating Factor
8%
Fc Receptor
8%
Metastasis
8%
Medicine and Dentistry
Immune Response
63%
Natural Killer Cell
56%
Cancer Immunotherapy
50%
Severe Acute Respiratory Syndrome Coronavirus 2
42%
Metastatic Carcinoma
34%
COVID-19 Vaccination
33%
Neoplasm
32%
Cytokine Response
27%
Receptor
25%
Cytotoxic T-Cell
24%
Diseases
23%
Immunoglobulin
22%
Oncology
22%
Immunotherapy
22%
In Vitro
19%
Cancer Therapy
19%
COVID-19
19%
T-Cell Response
18%
Gut Microbiota
16%
Translational Research
16%
Respiratory Disease
16%
Colorectal Carcinoma
16%
Immune-Related Adverse Events
16%
Herpes Labialis
16%
Antigen Specificity
16%
Virus Antigen
16%
Lymphocyte
16%
Carboxyfluorescein Diacetate Succinimidyl Ester
16%
Tumor Immunity
16%
Lifespan
16%
Lymphoid Cell
16%
Virus Nucleocapsid
16%
Protein Antibody
16%
Bifidobacterium
16%
Antibiotics
16%
T Cell
15%
Malignant Neoplasm
14%
Immunity
12%
Pneumococcus Vaccine
11%
Melanoma
10%
Combination Therapy
10%
Cancer Treatment
10%
Placebo
9%
Specific Tumor
9%
Pathogen
9%
T-Helper Cell
9%
Immune Checkpoint Blockade
9%
Cytokine
8%
Randomized Controlled Trial
8%
Clinical Trial
8%
